Results 191 to 200 of about 12,585 (215)

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective

Microorganisms, 2020
Diletta Rosati, Mariolina Bruno, Martin Jaeger   +2 more
exaly  

Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy

Drug Design, Development and Therapy, 2023
exaly  

Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis

New England Journal of Medicine, 2004
Jack D Sobel
exaly  

Oral Ibrexafungerp: an investigational agent for the treatment of vulvovaginal candidiasis

Expert Opinion on Investigational Drugs, 2020
Jack D Sobel
exaly  

Recurrent Vulvovaginal Candidiasis

Advances in Family Practice Nursing, 2022
openaire   +1 more source

Chronic vulvovaginal candidiasis.

American family physician, 2001
Frequently ignored by the medical community, chronic vulvovaginal symptoms are relatively common and can frustrating for patients and physicians. Establishing a proper diagnosis will lay the foundation for an effective therapeutic therapeutic plan. Fungal cultures are an important component of the work-up.
openaire   +1 more source

Global burden of recurrent vulvovaginal candidiasis: a systematic review

Lancet Infectious Diseases, The, 2018
Matthew Kneale, Jack D Sobel
exaly  

Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations

American Journal of Obstetrics and Gynecology, 1998
Jack D Sobel, Betsy Foxman
exaly  

Vulvovaginal Candidiasis: A Current Understanding and Burning Questions

Journal of Fungi (Basel, Switzerland), 2020
Brian M Peters, Junyan Liu, Zhenbo Xu
exaly  

VULVOVAGINAL CANDIDIASIS

InPharma, 1977
openaire   +1 more source